We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

1st Circuit Affirms Dismissal Of All But 1 Fabrazyme Shortage Claim

(June 1, 2016, 7:00 AM EDT) -- BOSTON — The First Circuit U.S. Court of Appeals on May 23 said only one plaintiff in two class actions pleaded an injury claim from a shortage of the drug Fabrazyme...
To view the full article, register now.